|
Immunomedics to Present at Cowen and Company 34th Annual Health Care …
Virtual-Strategy Magazine (press release) We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or “naked” form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins, … |
|
Immunomedics to Present at Cowen and Company 34th Annual Health Care …
NASDAQ We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or “naked” form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins, … |
Immunomedics to Present at Cowen and Company 34th Annual Health Care …MarketWatchWe also have a majority ownership in IBC Pharmaceuticals, Inc., which is developing a novel DOCK-AND-LOCK(TM) (DNL(TM)) method with us for making fusion proteins and mul…
Good reception for ReceptosU-T San DiegoMoussatos says Receptos is likely to be an even bigger success for MS than daclizumab, sold as by Roche as Zenapax. An estimated 400,000 people in the United States and 2.5 million people worldwide have multiple …
Medscape |
KIR4.1 Antibodies in Blood May Precede MS by Years
Medscape Antibodies against the inward rectifying potassium channel (KIR4.1) protein may be present in blood of healthy patients destined to develop multiple sclerosis (MS), results of a small study suggest. “If our results can be replicated in larger … |
Research and Markets: Global Monoclonal Antibodies Partnering Terms and …Business Wire (press release)The report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals…
Counsel & Heal |
In multiple sclerosis, antibodies detected years before symptoms
Medical News Today Results of a small study suggest it may be possible, by detecting the presence of a blood biomarker, to predict whether a person is going to develop multiple sclerosis long before symptoms of the disease emerge. Multiple sclerosis (MS) is a disease … Antibodies may signal multiple sclerosis before symptoms appearFox News AAN: KIR4.1 Antibodies Present in Plasma in Pre-Clinical MSDoctors Lounge Marker May Flag MS Prior to Symptom OnsetMedPage Today The Epoch Times –Monthly Prescribing Reference –Guardian Liberty Voice all 47 news articles » |
Unique cattle antibodies offer clues to human immune systemsAgri-ViewThe unusual structure of certain antibodies found in cattle could add to understanding of the diversity of antibodies and their specific functions in the immune systems of humans. In …
|
Rituximab Doesn’t Alleviate Sjögren Symptoms at Week 24
Monthly Prescribing Reference (HealthDay News) — For patients with primary Sjögren syndrome (pSS), rituximab does not improve symptoms or disease activity at 24 weeks, according to a study published in the February 18 issue of the Annals of Internal Medicine. |
Tech Times |
Antibodies may signal multiple sclerosis before symptoms appear
Fox News According to a new study to be presented at the American Academy of Neurology’s annual meeting, the appearance of antibodies against a potassium channel protein may be an indicator for MS before clinical symptoms present. For their research, German … AAN: KIR4.1 Antibodies Present in Plasma in Pre-Clinical MSDoctors Lounge Marker May Flag MS Prior to Symptom OnsetMedPage Today Antibody Test May Detect MS Before OnsetMonthly Prescribing Reference Guardian Liberty Voice –News-Medical.net all 42 news articles » |